Enliven Therapeutics, Inc. (ELVN)

Last Three Months

29-Dec-23 -- 28-Mar-24

Time Period:
  • Three Months
  •  | 
  • Year

0 Net Amount
Buy:0--
Sell:0--

Company Sentiment

Other

Other

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
0
(3)
0
(2)
2
(1)
27
0
0
+1
0
+2
0
+3

Two Year Chart

29-Mar-22 -- 28-Mar-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
Yesterday 5:03 PM
View: 
25-Mar-24
Planned Option Sale
($210.66K)
Kintz Samuel
President and CEO
Director
Insider Trading Sentiment for Kintz Samuel at Enliven Therapeutics, Inc. (ELVN):Enliven Therapeutics, Inc. - ELVN0%
1.26M
0
0
---- Show TxnsShow Insider Trades
29-Feb-24 5:27 PM
View: 
27-Feb-24
Planned Option Sale
($55.16K)
Hohl Benjamin
Chief Financial Officer
Insider Trading Sentiment for Hohl Benjamin at Enliven Therapeutics, Inc. (ELVN):Enliven Therapeutics, Inc. - ELVN0%
--
0
0
---- Show TxnsShow Insider Trades
04-Mar-24 5:55 PM
View: 
29-Feb-24
Planned Option Sale
($197.01K)
Lyssikatos Joseph P
Chief Scientific Officer
Director
Insider Trading Sentiment for Lyssikatos Joseph P at Enliven Therapeutics, Inc. (ELVN):Enliven Therapeutics, Inc. - ELVN0%
1.12M
0
0
---- Show TxnsShow Insider Trades
08-Mar-24 7:52 PM
View: 
06-Mar-24
Private Sale (Planned)
($76.24K)
Patel Anish
Chief Operating Officer
Insider Trading Sentiment for Patel Anish at Enliven Therapeutics, Inc. (ELVN):Enliven Therapeutics, Inc. - ELVN(6%)
427.14K to 401.5K
0
0
---- Show TxnsShow Insider Trades
21-Mar-24 6:41 PM
View: 
19-Mar-24
Private Sale (Planned)
($18.42K)
Insider Trading Sentiment for Heyman Richard A. at Enliven Therapeutics, Inc. (ELVN):Enliven Therapeutics, Inc. - ELVN(2%)
213.9K to 210.09K
0
0
---- Show TxnsShow Insider Trades
16-Feb-24 4:15 PM
View: 
14-Feb-24
Private Sale
($12.29M)
Insider Trading Sentiment for 5am Partners Vi, LLC at Enliven Therapeutics, Inc. (ELVN):Enliven Therapeutics, Inc. - ELVN(26%)
5.16M to 3.84M
0
0
---- Show TxnsShow Insider Trades
22-Mar-24 7:46 PM
View: 
20-Mar-24
Planned Option Sale
($254.46K)
Ballal Rahul D.
Director
Insider Trading Sentiment for Ballal Rahul D. at Enliven Therapeutics, Inc. (ELVN):Enliven Therapeutics, Inc. - ELVN0%
22.34K
0
0
---- Show TxnsShow Insider Trades